Tianyu He

IRS-Assisted Communication for B5G Networks By

Tianyu He, 2021 .

Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B

J. Jia, X. Ou, Tianyu He, 2018, Hepatology International.

Chronic HBV: which pregnant women should be treated?

J. Jia, Tianyu He, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Correction to: Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B

J. Jia, X. Ou, Tianyu He, 2018, Hepatology International.